These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36980931)

  • 1. Identification of Two Homozygous Variants in
    Szulik MW; Reyes-Múgica M; Marker DF; Gomez AM; Zinn MD; Walsh LK; Ochoa JP; Franklin S; Ghaloul-Gonzalez L
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of the South Asian
    Harper AR; Bowman M; Hayesmoore JBG; Sage H; Salatino S; Blair E; Campbell C; Currie B; Goel A; McGuire K; Ormondroyd E; Sergeant K; Waring A; Woodley J; Kramer CM; Neubauer S; Farrall M; Watkins H; Thomson KL;
    Circ Genom Precis Med; 2020 Jun; 13(3):e002783. PubMed ID: 32163302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A de novo mutation of SMYD1 (p.F272L) is responsible for hypertrophic cardiomyopathy in a Chinese patient.
    Fan LL; Ding DB; Huang H; Chen YQ; Jin JY; Xia K; Xiang R
    Clin Chem Lab Med; 2019 Mar; 57(4):532-539. PubMed ID: 30205637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish.
    Zahka K; Kalidas K; Simpson MA; Cross H; Keller BB; Galambos C; Gurtz K; Patton MA; Crosby AH
    Heart; 2008 Oct; 94(10):1326-30. PubMed ID: 18467358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The «Amish» NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation.
    Redin C; Pavlidou DC; Bhuiyan Z; Porretta AP; Monney P; Bedoni N; Maurer F; Sekarski N; Atallah I; Émeline D; Jeanrenaud X; Pruvot E; Fellay J; Superti-Furga A
    Eur J Med Genet; 2022 Dec; 65(12):104627. PubMed ID: 36162733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel
    Peng Y; Xu J; Wang Y; Zhao J; Zhang L; Chen Z; Jiang Y; Banerjee S; Zhang Z; Bai M
    Balkan J Med Genet; 2022 Jun; 25(1):71-78. PubMed ID: 36880031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a variant hotspot in MYBPC3 and of a novel CSRP3 autosomal recessive alteration in a cohort of Polish patients with hypertrophic cardiomyopathy.
    Lipari M; Wypasek E; Karpiński M; Tomkiewicz-Pajak L; Laino L; Binni F; Giannarelli D; Rubiś P; Petkow-Dimitrow P; Undas A; Grammatico P; Bottillo I
    Pol Arch Intern Med; 2020 Feb; 130(2):89-99. PubMed ID: 31919335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes.
    Field E; Norrish G; Acquaah V; Dady K; Cicerchia MN; Ochoa JP; Syrris P; McLeod K; McGowan R; Fell H; Lopes LR; Cervi E; Kaski JPP
    J Med Genet; 2022 Aug; 59(8):768-775. PubMed ID: 34400558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and Functional Distribution of
    Helms AS; Thompson AD; Glazier AA; Hafeez N; Kabani S; Rodriguez J; Yob JM; Woolcock H; Mazzarotto F; Lakdawala NK; Wittekind SG; Pereira AC; Jacoby DL; Colan SD; Ashley EA; Saberi S; Ware JS; Ingles J; Semsarian C; Michels M; Olivotto I; Ho CY; Day SM
    Circ Genom Precis Med; 2020 Oct; 13(5):396-405. PubMed ID: 32841044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy.
    Kissopoulou A; Trinks C; Green A; Karlsson JE; Jonasson J; Gunnarsson C
    ESC Heart Fail; 2018 Aug; 5(4):716-723. PubMed ID: 29663722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
    Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
    J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
    Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy.
    Xin B; Puffenberger E; Tumbush J; Bockoven JR; Wang H
    Am J Med Genet A; 2007 Nov; 143A(22):2662-7. PubMed ID: 17937428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy: two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy.
    Nanni L; Pieroni M; Chimenti C; Simionati B; Zimbello R; Maseri A; Frustaci A; Lanfranchi G
    Biochem Biophys Res Commun; 2003 Sep; 309(2):391-8. PubMed ID: 12951062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank.
    Park J; Packard EA; Levin MG; Judy RL; ; Damrauer SM; Day SM; Ritchie MD; Rader DJ
    Hum Mol Genet; 2022 Mar; 31(5):827-837. PubMed ID: 34542152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
    Suay-Corredera C; Pricolo MR; Herrero-Galán E; Velázquez-Carreras D; Sánchez-Ortiz D; García-Giustiniani D; Delgado J; Galano-Frutos JJ; García-Cebollada H; Vilches S; Domínguez F; Molina MS; Barriales-Villa R; Frisso G; Sancho J; Serrano L; García-Pavía P; Monserrat L; Alegre-Cebollada J
    J Biol Chem; 2021 Jul; 297(1):100854. PubMed ID: 34097875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
    Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
    J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.